Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

NEO holding history

Neogenomics Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NEO overviewAll 13F holders of NEOFull Q2 2026 holdings

Shares (Q2 2026)
2,194,758
Value
$32.0M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of NEO by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,194,758$32.0M<0.1%−1,969,425−47.3%ReducedHolders
Q1 20264,164,183$30.9M<0.1%−1,133,345−21.4%ReducedHolders
Q4 20255,297,528$62.3M<0.1%+2,000,123+60.7%AddedHolders
Q3 20253,297,405$25.5M<0.1%+2,362,229+252.6%AddedHolders
Q2 2025935,176$6.84M<0.1%+935,176NewHolders
Q1 20250$00.0%−39,909−100.0%Sold outHolders
Q4 202439,909$657.7K<0.1%−19,819−33.2%ReducedHolders
Q3 202459,728$881.0K<0.1%−106,828−64.1%ReducedHolders
Q2 2024166,556$2.31M<0.1%+21,268+14.6%AddedHolders
Q1 2024145,288$2.28M<0.1%−248,891−63.1%ReducedHolders
Q4 2023394,179$6.38M<0.1%−382,283−49.2%ReducedHolders
Q3 2023776,462$9.55M<0.1%−117,493−13.1%ReducedHolders
Q2 2023893,955$14.4M<0.1%+69,974+8.5%AddedHolders
Q1 2023823,981$14.3M<0.1%−164,198−16.6%ReducedHolders
Q4 2022988,179$9.13M<0.1%+354,978+56.1%AddedHolders
Q3 2022633,201$5.45M<0.1%−375,885−37.3%ReducedHolders
Q2 20221,009,086$8.22M<0.1%+979,787+3,344.1%AddedHolders
Q1 202229,299$356.0K<0.1%+29,299NewHolders
Q2 20210$00.0%−9,497−100.0%Sold outHolders
Q1 20219,497$458.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.